# Orphazyme A/S (ORPH)

Source: https://www.quantisnow.com/company/ORPH
Generated: 2026-11-12T11:07:33.975Z

- Ticker: ORPH
- Exchange: NASDAQ
- Sector: Technology
- Industry: Computer Software: Prepackaged Software
- IPO year: 2020
- Website: orphazyme.com

## About

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

## Latest ORPH news and filings

- 2022-06-29 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-3090787)
- 2022-06-28 20:36 UTC [SEC Form 20-F filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-orphazyme-as-3084470)
- 2022-06-21 20:18 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-3053225)
- 2022-05-31 20:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2967711)
- 2022-05-23 20:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2929980)
- 2022-05-18 21:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2912371)
- 2022-05-16 20:12 UTC [SEC Form NT 20-F/A filed by Orphazyme A/S (Amendment)](https://www.quantisnow.com/insight/sec-form-nt-20-fa-filed-by-orphazyme-as-amendment-2896252)
- 2022-05-16 20:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2896123)
- 2022-05-16 12:38 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2890972)
- 2022-05-02 21:16 UTC [SEC Form NT 20-F filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-nt-20-f-filed-by-orphazyme-as-2812898)
- 2022-04-29 11:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2795923)
- 2022-04-29 11:39 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2795898)
- 2022-04-07 10:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2690579)
- 2022-04-06 13:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2686260)
- 2022-04-06 10:39 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2684524)
- 2022-04-06 09:33 UTC [Market Insight] [Orphazyme Announced Notice Received from the Depositary to Holders of ADSs Regarding Termination of Deposit Agreement](https://www.quantisnow.com/insight/orphazyme-announced-notice-received-from-the-depositary-to-holders-of-2684236)
- 2022-04-04 21:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2674593)
- 2022-03-31 21:31 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-orphazyme-as-2660985)
- 2022-03-31 19:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2658160)
- 2022-03-31 16:03 UTC [Market Chatter] [Orphazyme Reports An Enclosed Proposal For Statutory Restructuring Plan Will Be Submitted To Danish Maritime, Commercial High Court](https://www.quantisnow.com/insight/orphazyme-reports-an-enclosed-proposal-for-statutory-restructuring-plan-will-2656545)
- 2022-03-29 11:42 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2637445)
- 2022-03-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-effect-filed-by-orphazyme-as-2618047)
- 2022-03-22 16:23 UTC [Market Insight] [Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs](https://www.quantisnow.com/insight/orphazyme-withdraws-european-application-for-arimoclomol-initiates-delisting-of-its-2608305)
- 2022-03-22 12:31 UTC [Market Insight] [The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout](https://www.quantisnow.com/insight/the-daily-biotech-pulse-mercks-keytruda-snags-another-fda-approval-2606211)
- 2022-03-22 11:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2605503)
- 2022-03-22 10:59 UTC [Market Insight] [Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C](https://www.quantisnow.com/insight/orphazyme-announces-withdrawal-of-european-marketing-authorisation-application-for-arimoclomol-2605231)
- 2022-03-22 10:48 UTC [Market Insight] [30 Stocks Moving in Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/30-stocks-moving-in-tuesdays-pre-market-session-2605199)
- 2022-03-21 22:19 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-2604198)
- 2022-03-21 20:36 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-orphazyme-as-2603567)
- 2022-03-21 20:33 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-orphazyme-as-2603537)
- 2022-03-21 20:27 UTC [SEC Form POS AM filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-orphazyme-as-2603460)
- 2022-03-21 20:23 UTC [SEC Form 25 filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-25-filed-by-orphazyme-as-2603427)
- 2022-03-18 12:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by Orphazyme A/S](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-orphazyme-as-2594813)
- 2022-03-18 10:53 UTC [Market Chatter] [Orphazyme Notice Of In-Court Restructuring Proceedings; Court Named Attorney John Sommer Schmidt As Restructuring Admin.](https://www.quantisnow.com/insight/orphazyme-notice-of-in-court-restructuring-proceedings-court-named-attorney-john-2594398)
- 2022-03-18 09:23 UTC [Market Insight] [64 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/64-biggest-movers-from-yesterday-2594089)
- 2022-03-17 19:09 UTC [Market Insight] [Orphazyme shares are trading higher. Not seeing any company-specific news to justify the price action.](https://www.quantisnow.com/insight/orphazyme-shares-are-trading-higher-not-seeing-any-company-specific-news-2591173)
- 2022-03-17 16:35 UTC [Market Insight] [31 Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/31-stocks-moving-in-thursdays-mid-day-session-2590325)
- 2022-03-17 13:09 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-2588905)
- 2022-03-17 11:40 UTC [Market Insight] [22 Stocks Moving in Thursday's Pre-Market Session](https://www.quantisnow.com/insight/22-stocks-moving-in-thursdays-pre-market-session-2587843)
- 2022-03-14 16:11 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-2568442)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ORPH
- Earnings history: https://www.quantisnow.com/earnings/ORPH
- Dividend history: https://www.quantisnow.com/dividends/ORPH
- Insider transactions: https://www.quantisnow.com/insiders/ORPH
- Options chain: https://www.quantisnow.com/options/ORPH
- SEC 8-K filings only: https://www.quantisnow.com/company/ORPH/8-k
- RSS and alerts for ORPH: https://www.quantisnow.com/docs/rss-feeds.md